Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

Biomed Res Ther. 2015; 2(10): 374-384


Significance of p53, pRb and Ki-67 markers in Cervical intraepithelial lesion and Malignancy

Kalyani Raju, Shruthi Suresh Punnayanapalya, Narayanaswamy Mariyappa.




Abstract

OBJECTIVE: To study and to derive the significance of expression of p53, pRb and Ki-67 markers in various grades of cervical intraepithelial lesions and malignancy in a tertiary hospital situated in southern part of India which caters the rural and semi-urban population.

METHODS: A total of 120 cervical tissue samples were included. These represented normal, dysplasia and malignancy. Immunohistochemical staining was performed for p53, Ki-67 and pRb in formalin-fixed, paraffin-embedded tissue sections of the uterine cervix using horse-peroxidase method. Descriptive statistical analysis was done; significance was assessed at 5% level of significance. The mean value of the markers was compared between normal and pathological lesions separately using Independent “t” test.

RESULTS: There was significant association of p53 expression between normal cervical epithelium and low grade squamous intraepithelial lesion (LSIL) (p=0.023), squamous cell carcinoma (SCC) (p

Key words: Cervical carcinoma, Low grade squamous intraepithelial lesion, High grade squamous intraepithelial lesion, Squamous cell carcinoma, Adenocarcinoma, p53, Ki-67, pRb






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.